Gefapixant Promising for Relief of Unexplained Chronic Cough
Cough frequency significantly reduced after 12 weeks of gefapixant 50 mg versus placebo in phase 2b study
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Allergy, Pharmacy, Pulmonology, Journal, Source Type: news
More News: Allergy | Allergy & Immunology | Cough | Internal Medicine | Respiratory Medicine | Study